Lars Verschuren

5.3k total citations · 1 hit paper
83 papers, 4.2k citations indexed

About

Lars Verschuren is a scholar working on Epidemiology, Physiology and Molecular Biology. According to data from OpenAlex, Lars Verschuren has authored 83 papers receiving a total of 4.2k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Epidemiology, 28 papers in Physiology and 26 papers in Molecular Biology. Recurrent topics in Lars Verschuren's work include Liver Disease Diagnosis and Treatment (27 papers), Cholesterol and Lipid Metabolism (10 papers) and Adipokines, Inflammation, and Metabolic Diseases (10 papers). Lars Verschuren is often cited by papers focused on Liver Disease Diagnosis and Treatment (27 papers), Cholesterol and Lipid Metabolism (10 papers) and Adipokines, Inflammation, and Metabolic Diseases (10 papers). Lars Verschuren collaborates with scholars based in Netherlands, United States and Germany. Lars Verschuren's co-authors include Robert Kleemann, Teake Kooistra, Martine C. Morrison, P. Hans, Kanita Salic, Susanne Zadelaar, Jaap Keijer, Eveline Gart, Joline Attema and Peter Y. Wielinga and has published in prestigious journals such as Blood, PLoS ONE and Circulation Research.

In The Last Decade

Lars Verschuren

82 papers receiving 4.1k citations

Hit Papers

Diet-Independent Correlations between Bacteria and Dysfun... 2018 2026 2020 2023 2018 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Diet-Independent Correlations between Bacteria and Dysfunction of Gut, Adipose Tissue, and Liver: A Comprehensive Microbiota Analysis in Feces and Mucosa of the Ileum and Colon in Obese Mice with NAFLD
    2018 989 citations Eveline Gart, Frank Schuren et al. International Journal of Molecular Sciences profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lars Verschuren Netherlands 32 1.5k 991 788 724 679 83 4.2k
Stefano Menini Italy 41 1.3k 0.9× 581 0.6× 472 0.6× 889 1.2× 776 1.1× 72 4.0k
Aldo Paolicchi Italy 39 1.7k 1.2× 1.3k 1.3× 585 0.7× 486 0.7× 295 0.4× 142 5.8k
Andrey V. Grechko Russia 33 1.7k 1.2× 719 0.7× 803 1.0× 486 0.7× 1.1k 1.6× 156 4.5k
Yong Xu China 37 1.9k 1.3× 487 0.5× 424 0.5× 871 1.2× 469 0.7× 140 4.0k
Jean-Paul Paı̈s de Barros France 34 1.7k 1.1× 421 0.4× 983 1.2× 456 0.6× 513 0.8× 123 3.7k
Eva Kassi Greece 33 1.1k 0.7× 1.1k 1.1× 583 0.7× 587 0.8× 335 0.5× 161 4.6k
Jinhan He China 35 1.7k 1.1× 1.6k 1.6× 732 0.9× 1.2k 1.7× 270 0.4× 102 4.9k
Chaodong Wu United States 40 2.5k 1.7× 1.5k 1.5× 799 1.0× 1.2k 1.6× 553 0.8× 127 5.1k
Hunjoo Ha South Korea 49 2.8k 1.9× 801 0.8× 1.2k 1.5× 1.1k 1.5× 729 1.1× 167 7.8k
Gianna Ferretti Italy 41 1.1k 0.7× 845 0.9× 1.0k 1.3× 496 0.7× 517 0.8× 155 5.6k

Countries citing papers authored by Lars Verschuren

Since Specialization
Citations

This map shows the geographic impact of Lars Verschuren's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lars Verschuren with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lars Verschuren more than expected).

Fields of papers citing papers by Lars Verschuren

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lars Verschuren. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lars Verschuren. The network helps show where Lars Verschuren may publish in the future.

Co-authorship network of co-authors of Lars Verschuren

This figure shows the co-authorship network connecting the top 25 collaborators of Lars Verschuren. A scholar is included among the top collaborators of Lars Verschuren based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lars Verschuren. Lars Verschuren is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Morrison, Martine C., Arianne van Koppen, Eveline Gart, et al.. (2025). Fibrogenic Gene Signature as Early Prediction for the Efficacy of Pharmacological Interventions for MASH ‐Associated Fibrosis. The FASEB Journal. 39(12). e70735–e70735. 1 indexed citations
2.
Gart, Eveline, Jessica Snabel, Lars Verschuren, et al.. (2025). Biomarkers of Metabolism and Inflammation in Individuals with Obesity and Normal Weight: A Comparative Analysis Exploring Sex Differences. International Journal of Molecular Sciences. 26(15). 7576–7576.
3.
Caspers, Martien P. M., Nanda Keijzer, Robert Kleemann, et al.. (2024). Translatability of mouse muscle-aging for humans: the role of sex. GeroScience. 46(3). 3341–3360. 7 indexed citations
4.
Caspers, Martien P. M., Jessica Snabel, Feike R. van der Leij, et al.. (2024). Blood-based biomarkers for early frailty are sex-specific: validation of a combined in silico prediction and data-driven approach. GeroScience. 47(3). 3741–3758. 1 indexed citations
5.
Zhan, Na, Frank Leijten, Martien P. M. Caspers, et al.. (2024). Supplementation of Seaweed Extracts to the Diet Reduces Symptoms of Alzheimer’s Disease in the APPswePS1ΔE9 Mouse Model. Nutrients. 16(11). 1614–1614. 6 indexed citations
6.
Attema, Joline, Aswin Menke, Martien P. M. Caspers, et al.. (2024). Therapeutic effects of FGF21 mimetic bFKB1 on MASH and atherosclerosis in Ldlr−/−.Leiden mice. The FASEB Journal. 38(20). e70087–e70087. 3 indexed citations
7.
Hernández, Manuel A. González, Lars Verschuren, Martien P. M. Caspers, et al.. (2024). Identifying patient subgroups in MASLD and MASH-associated fibrosis: molecular profiles and implications for drug development. Scientific Reports. 14(1). 23362–23362. 4 indexed citations
8.
Stokman, Geurt, Martine C. Morrison, Lars Verschuren, et al.. (2023). Semaglutide Has Beneficial Effects on Non-Alcoholic Steatohepatitis in Ldlr-/-.Leiden Mice. International Journal of Molecular Sciences. 24(10). 8494–8494. 18 indexed citations
9.
Stokman, Geurt, Elsbet Pieterman, Martine C. Morrison, et al.. (2023). Atorvastatin Attenuates Diet-Induced Non-Alcoholic Steatohepatitis in APOE*3-Leiden Mice by Reducing Hepatic Inflammation. International Journal of Molecular Sciences. 24(9). 7818–7818. 12 indexed citations
10.
Kleemann, Robert, Wim van Duyvenvoorde, Nanda Keijzer, et al.. (2022). Therapeutic Intervention with Anti-Complement Component 5 Antibody Does Not Reduce NASH but Does Attenuate Atherosclerosis and MIF Concentrations in Ldlr-/-.Leiden Mice. International Journal of Molecular Sciences. 23(18). 10736–10736. 9 indexed citations
11.
Gart, Eveline, Wim van Duyvenvoorde, Karin Toet, et al.. (2021). Butyrate Protects against Diet-Induced NASH and Liver Fibrosis and Suppresses Specific Non-Canonical TGF-β Signaling Pathways in Human Hepatic Stellate Cells. Biomedicines. 9(12). 1954–1954. 33 indexed citations
12.
Stokman, Geurt, Anita M. van den Hoek, Elsbet Pieterman, et al.. (2020). Dual targeting of hepatic fibrosis and atherogenesis by icosabutate, an engineered eicosapentaenoic acid derivative. Liver International. 40(11). 2860–2876. 15 indexed citations
13.
Pouwer, Marianne, Elsbet Pieterman, Shu‐Ching Chang, et al.. (2019). Dose Effects of Ammonium Perfluorooctanoate on Lipoprotein Metabolism in APOE*3-Leiden.CETP Mice. Toxicological Sciences. 168(2). 519–534. 27 indexed citations
14.
Salic, Kanita, Eveline Gart, Lars Verschuren, et al.. (2019). Combined Treatment with L-Carnitine and Nicotinamide Riboside Improves Hepatic Metabolism and Attenuates Obesity and Liver Steatosis. International Journal of Molecular Sciences. 20(18). 4359–4359. 38 indexed citations
15.
Salic, Kanita, Robert Kleemann, Cynthia E. Wilkins-Port, et al.. (2019). Apical sodium-dependent bile acid transporter inhibition with volixibat improves metabolic aspects and components of non-alcoholic steatohepatitis in Ldlr-/-.Leiden mice. PLoS ONE. 14(6). e0218459–e0218459. 37 indexed citations
16.
Gart, Eveline, Frank Schuren, Joline Attema, et al.. (2018). Diet-Independent Correlations between Bacteria and Dysfunction of Gut, Adipose Tissue, and Liver: A Comprehensive Microbiota Analysis in Feces and Mucosa of the Ileum and Colon in Obese Mice with NAFLD. International Journal of Molecular Sciences. 20(1). 1–1. 989 indexed citations breakdown →
17.
Morrison, Martine C., Lars Verschuren, Kanita Salic, et al.. (2018). Obeticholic Acid Modulates Serum Metabolites and Gene Signatures Characteristic of Human NASH and Attenuates Inflammation and Fibrosis Progression in Ldlr‐/‐.Leiden Mice. Hepatology Communications. 2(12). 1513–1532. 53 indexed citations
18.
Salic, Kanita, Martine C. Morrison, Lars Verschuren, et al.. (2016). Resolvin E1 attenuates atherosclerosis in absence of cholesterol-lowering effects and on top of atorvastatin. Atherosclerosis. 250. 158–165. 92 indexed citations
19.
Morrison, Martine C., Peter Heeringa, Eric L. Kaijzel, et al.. (2014). Epicatechin attenuates atherosclerosis and exerts anti-inflammatory effects on diet-induced human-CRP and NFκB in vivo. Atherosclerosis. 233(1). 149–156. 71 indexed citations
20.
Kleemann, Robert, Lars Verschuren, Marjan J. van Erk, et al.. (2007). Increased dietary cholesterol-induced atherosclerosis is associated with liver inflammation: Identification of novel regulatory pathways and transcriptional regulators involved in switch from metabolic adaptation to inflammatory state.. Genome biology. 8. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Stefano Menini Breakdown of academic impact, for papers by Aldo Paolicchi Breakdown of academic impact, for papers by Andrey V. Grechko Breakdown of academic impact, for papers by Yong Xu Breakdown of academic impact, for papers by Jean-Paul Paı̈s de Barros Breakdown of academic impact, for papers by Eva Kassi Breakdown of academic impact, for papers by Jinhan He Breakdown of academic impact, for papers by Chaodong Wu Breakdown of academic impact, for papers by Hunjoo Ha Breakdown of academic impact, for papers by Gianna Ferretti
Rankless by CCL
2026